Aug 3, 2026 04:05PM
Aug 3, 2026 08:05AM
Aug 3, 2026 08:05AM
Jul 29, 2026 08:05AM
Jul 8, 2026 04:05PM
Jul 1, 2026 04:05PM
Jun 30, 2026 08:05AM Candel Therapeutics launches phase 3 lung cancer trial for CAN-2409
Jun 30, 2026 08:05AM
Jun 25, 2026 08:05AM
Jun 25, 2026 08:05AM
Jun 2, 2026 08:05AM
Jun 2, 2026 08:05AM
Jun 1, 2026 04:05PM
May 15, 2026 04:05PM Candel Therapeutics reports extended clinical benefits in phase 3 prostate cancer trial
May 15, 2026 04:05PM
May 14, 2026 08:05AM
May 13, 2026 08:05AM
May 4, 2026 08:05AM
May 4, 2026 08:05AM
May 1, 2026 04:05PM
Apr 29, 2026 08:05AM Candel Therapeutics partners with EVERSANA for drug commercialization
Apr 29, 2026 08:05AM
Apr 2, 2026 04:05PM
Mar 17, 2026 08:05AM
Mar 17, 2026 08:05AM
Mar 13, 2026 06:10AM
Mar 12, 2026 08:05AM
Mar 9, 2026 08:05AM Candel Therapeutics to present prostate cancer trial data at AUA meeting
Mar 9, 2026 08:05AM
Mar 2, 2026 04:05PM
Feb 24, 2026 08:05AM
Feb 19, 2026 09:40PM
Feb 19, 2026 09:40PM
Feb 19, 2026 04:05PM
Feb 19, 2026 04:05PM Candel Therapeutics Announces Proposed $100 Million Public Offering
Feb 19, 2026 04:02PM
Feb 19, 2026 04:01PM
Feb 11, 2026 08:05AM
Feb 2, 2026 04:05PM
Nov 17, 2025 04:05PM
Nov 17, 2025 04:05PM
Nov 13, 2025 08:25AM Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Nov 4, 2025 09:00AM
Nov 4, 2025 09:00AM
Nov 3, 2025 08:05AM
Oct 16, 2025 08:05AM
Oct 16, 2025 08:05AM
Oct 14, 2025 08:12AM
Oct 14, 2025 08:10AM Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
Oct 14, 2025 08:10AM

328,148 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All